Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has ended its US partnership with consumer health giant Haleon PLC (LSE:HLN, ...

Futura Medical reports 'highly positive' data for female sexual health treatment

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind the erectile dysfunction gel Eroxon, ...
Proactiveinvestors UK

Futura Medical highlights regulatory and commercial progress of erectile dysfunction treatment candidate

The Small Cap Wrap: Inflation cools, boards are strengthened and more ...
The Washington Post

A new treatment for erectile dysfunction isn’t a pill. It’s a gel.

Eroxon, a topical gel intended to treat erectile dysfunction, may soon be available in the United States. The Food and Drug Administration authorized the marketing of the product as a medical device ...